posted on 2018-01-05, 15:05authored byBaptiste Coudrillier, Ian C. Campbell, Thomas A. Read, Diogo M. Geraldes, Nghia T. Vo, Andrew J. Feola, John J.E. Mulvihill, Julie Albon, Richard L. Abel, Ross C. Ethier
PURPOSE. Scleral stiffening has been proposed as a treatment for glaucoma to protect the
lamina cribrosa (LC) from excessive intraocular pressure–induced deformation. Here we
experimentally evaluated the effects of moderate stiffening of the peripapillary sclera on the
deformation of the LC.
METHODS. An annular sponge, saturated with 1.25% glutaraldehyde, was applied to the
external surface of the peripapillary sclera for 5 minutes to stiffen the sclera. Tissue
deformation was quantified in two groups of porcine eyes, using digital image correlation
(DIC) or computed tomography imaging and digital volume correlation (DVC). In group A (n
¼ 14), eyes were subjected to inflation testing before and after scleral stiffening. Digital image
correlation was used to measure scleral deformation and quantify the magnitude of scleral
stiffening. In group B (n ¼ 5), the optic nerve head region was imaged using synchrotron
radiation phase-contrast microcomputed tomography (PC lCT) at an isotropic spatial
resolution of 3.2 lm. Digital volume correlation was used to compute the full-field threedimensional
deformation within the LC and evaluate the effects of peripapillary scleral crosslinking
on LC biomechanics.
RESULTS. On average, scleral treatment with glutaraldehyde caused a 34 6 14% stiffening of
the peripapillary sclera measured at 17 mm Hg and a 47 6 12% decrease in the maximum
tensile strain in the LC measured at 15 mm Hg. The reduction in LC strains was not due to
cross-linking of the LC.
CONCLUSIONS. Peripapillary scleral stiffening is effective at reducing the magnitude of
biomechanical strains within the LC. Its potential and future utilization in glaucoma axonal
neuroprotection requires further investigation.
History
Publication
Investigative Ophthalmology & Visual Science;57, pp. 2666-2677
Publisher
Association for Research in Vision and Ophthalmology (ARVO)
Note
peer-reviewed
Other Funding information
Science and Technology Facilities Council, Georgia Research Alliance, National Eye Institute, Department of Veterans Affairs